论文部分内容阅读
急性心肌梗死(AMI)微循环血管痉挛、血栓形成等因素是造成AMI经皮冠状动脉成形术(PCI)后预后不良的主要原因。前列地尔是临床广泛应用的微血管扩张剂,而丹红注射液具有扩冠、抗栓作用。笔者观察了前列地尔联合丹红注射液用于AMI延迟PCI术后患者的疗效,现报告如下。1资料与方法1.1临床资料选择2010年2月至2014年3月于舞钢职工医院接受PCI治疗的AMI患者85例。
Acute myocardial infarction (AMI) Microcirculation Vasospasm, thrombosis and other factors is caused by AMI after percutaneous transluminal coronary angioplasty (PCI) the main reason for poor prognosis. Alprostadil is a widely used clinical microvascular vasodilator, and Danhong injection has the crown, antithrombotic effect. The author observed alprostadil combined Danhong injection for AMI in patients with delayed PCI efficacy, are as follows. 1 Materials and Methods 1.1 Clinical data selected from February 2010 to March 2014 in Wugang Workers Hospital PCI treatment of 85 patients with AMI.